Machine learning in prediction of epidermal growth factor receptor status in non-small cell lung cancer brain metastases: a systematic review and meta-analysis
Open Access
- 1 May 2025
- journal article
- review article
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-14
Abstract
Epidermal growth factor receptor (EGFR) mutations are present in 10–60% of all non-small cell lung cancer (NSCLC) patients and are associated with dismal prognosis. Lung cancer brain metastases (LCBM) are a common complication of lung cancer. Predictions of EGFR can help physicians in decision-making and, through optimizing treatment strategies, can result in more favorable outcomes. This systematic review and meta-analysis evaluated the predictive performance of machine learning (ML)-based models in EGFR status in NSCLC patients with brain metastasis. On December 20, 2024, the four electronic databases, Pubmed, Embase, Scopus, and Web of Science, were systematically searched. Studies that evaluated EGFR status in patients with brain metastasis from NSCLC were included. Twenty studies with 3517 patients with 6205 NSCLC brain metastatic lesions were included. The majority of the best-performance models were ML-based (70%, 7/10), and deep learning (DL)-based models comprised 30% (6/20) of models. The area under the curve (AUC) and accuracy (ACC) of the best-performance models ranged from 0.765 to 1 and 0.69 to 0.93, respectively. The meta-analysis of the best-performance model revealed a pooled AUC of 0.91 (95%CI: 0.88–0.93) and ACC of 0.82 (95%CI: 0.79–0.86) along with a pooled sensitivity of 0.87 (95%CI: 0.83–0.9), specificity of 0.86 (95%CI: 0.79–0.9), and diagnostic odds ratio (DOR) of 35.2 (95%CI: 21.2–58.4). The subgroup analysis did not show significant differences between ML and DL models. ML-based models demonstrated promising predictive outcomes in predicting EGFR status. Applying ML-based models in daily clinical practice can optimize treatment strategies and enhance clinical and radiological outcomes.Keywords
This publication has 63 references indexed in Scilit:
- Interpreting Black-Box Models: A Review on Explainable Artificial IntelligenceCognitive Computation, 2023
- Brain‐Tumor Interface‐Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR‐TKI and T790M Resistance Mutation in Non‐Small Cell Lung Carcinoma Brain MetastasisJournal of Magnetic Resonance Imaging, 2023
- Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLCEuropean Radiology, 2023
- Radiomics for prediction of response to EGFR-TKI based on metastasis/brain parenchyma (M/BP)-interfaceLa radiologia medica, 2022
- Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastasesJournal of Neuro-Oncology, 2022
- Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancerNeuroradiology, 2020
- Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal DiseaseTargeted Oncology, 2018
- A Critical Review for Developing Accurate and Dynamic Predictive Models Using Machine Learning Methods in Medicine and Health CareJournal of Medical Systems, 2017
- Routine EGFR Molecular Analysis in Non-Small-Cell Lung Cancer Patients is Feasible: Exons 18–21 Sequencing Results of 753 Patients and Subsequent Clinical OutcomesLung, 2013
- Management of brain metastases: the indispensable role of surgeryJournal of Neuro-Oncology, 2009